Find out how world-class academic research is commercialised by scientists, engineers, medical professionals, business leaders and policymakers at Manchester. Lynch syndrome is a genetic condition ...

Nouscom has announced full safety and immunogenicity results from its phase 1b/2 trial of NOUS-209, an off-the-shelf immunotherapy for Lynch Syndrome (LS). These findings will be shared in an oral ...